lymphatic filariasis

16
Lymphatic filariasis Elephantiasis

Upload: azuka

Post on 09-Feb-2016

222 views

Category:

Documents


1 download

DESCRIPTION

Lymphatic filariasis. Elephantiasis. Lymphatic filariasis is widespread and infects 120 million people. Lymphatic filariasis mainly affects tropical parts of the developing world. It is caused by the nematode Wuchereria bancrofti. responsible for 90% of the cases. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Lymphatic filariasis

Lymphatic filariasis

Elephantiasis

Page 2: Lymphatic filariasis

Lymphatic filariasis is widespread and infects 120 million people

Page 3: Lymphatic filariasis

Lymphatic filariasis mainly affects tropical parts of the developing world.

Page 4: Lymphatic filariasis

It is caused by the nematode Wuchereria bancrofti

◦ responsible for 90% of the cases

Page 5: Lymphatic filariasis

It is transmitted by mosquitos of several genera.

◦Culex◦Anopheles◦Aedes

Page 6: Lymphatic filariasis

Humans and mosquitos are the 2 hosts of the parasites.

Page 7: Lymphatic filariasis

Asymptomatic

Acute

Chronic

There are three types of infection.

Page 8: Lymphatic filariasis

Acute filariasis involves local inflammation of skin, lymphatic vessels and lymph nodes.

Page 9: Lymphatic filariasis

The chronic disease results in Lymphedema and Elephantiasis

Page 10: Lymphatic filariasis

Several studies suggest that the body’s immune response to the pathogen causes the most harm.

Page 11: Lymphatic filariasis

The only way to diagnose the disease is to identify microfilariae or adult worms in a patients blood using a microscope.

Page 12: Lymphatic filariasis

The drug of choice in treating lymphatic filariasis is diethylcarbamazine (DEC).

Page 13: Lymphatic filariasis

There is not thought to be a problem with resistance to DEC.

Page 14: Lymphatic filariasis

WHO’s Global Programme to Eliminate Lymphatic Filariasis has greatly increased treatment and decreased transmission by 43%.

Page 15: Lymphatic filariasis

There is a large social stigma against those with elephantiasis in many countries.

Page 16: Lymphatic filariasis

ReferencesEberhard, Mark L., Patrick J. Lammie, Charlotte M. Dickinson, and Jacqueline M. Roberts. "Evidence of Nonsusceptibility to Diethylcarbamazine in Wucheria Bancrofti." The Journal of Infectious Diseases, May 1991. Web. 2 Apr. 2012. <http://www.jstor.org/stable/30132517?seq=1>.  Heeren, Dan. "Elephantiasis." Davidson College, 2006. Web. 02 Apr. 2012. <http://www.bio.davidson.edu/courses/immunology/Students/spring2006/Heeren/ele ph.html>.  King CL, Kumaraswami V, Poindexter RW, Kumari S, Jayara-man K, Alling DW, Ottesen EA, Nutman TB. “Immunologic tol-erance in lymphatic filariasis. Diminished parasite-specific T and B lymphocyte precursor frequency in the microfilaremic state.” J Clin Invest. 1992 May;89(5):1403–1410. "Lymphatic Filariasis: Causes." Better Medicine, 2011. Web. 02 Apr. 2012. <http://www.localhealth.com/article/lymphatic-filariasis/causes>.  "Lymphatic Filariasis." WHO. Jan. 2012. Web. 02 Apr. 2012. <http://www.who.int/mediacentre/factsheets/fs102/en/>.  Wynd, Shona, Wayne D. Melrose, David N. Durheim, Jaime Carron, and Margaret Gyapong. "Understanding the Community Impact of Lymphatic Filariasis: A Review of the Sociocultural Literature." WHO. June 2007. Web. 02 Apr. 2012. <http://www.who.int/bulletin/volumes/85/6/06-031047/en/index.html>.